bENaC Acts as a Mechanosensor in Renal Vascular Smooth Muscle Cells That Contributes to Renal Myogenic Blood Flow Regulation, Protection From Renal Injury and Hypertension

 

 

Heather A. Drummond, David E. Stec

 

 

Heather A. Drummond, David E. Stec, Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, MS, 39216-4505, USA

Correspondence to: Heather A. Drummond, PhD, Associate Professor, Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, MS, 39216-4505, USA.

Email: hdrummond@umc.edu

Telephone: +1-601-984-1812       Fax: +1-601-984-1833

Received: May 6, 2015               Revised: May 27, 2015

Accepted: May 31, 2015

Published online: June 26, 2015

 

ABSTRACT

Pressure-induced constriction (also known as the myogenic response) is an important mechanodependent response in small renal arteries and arterioles. The response is initiated by vascular smooth muscle cell (VSMC) stretch due to an increase in intraluminal pressure and leads to vasoconstriction. The myogenic response has two important roles as a mechanism of local blood flow autoregulation and protection against systemic blood pressure-induced microvascular damage. However, the molecular mechanisms underlying initiation of myogenic response are unresolved. Although several molecules have been considered initiators of the response, our laboratory has focused on the role of degenerin proteins because of their strong evolutionary link to mechanosensing in the nematode. Our laboratory has addressed the hypothesis that certain degenerin proteins act as mechanosensors in VSMCs. This article discusses the importance of a specific degenerin protein, Epithelial Na+ Channel (ENaC), in pressure-induced vasoconstriction, renal blood flow and susceptibility to renal injury. We propose that loss of the renal myogenic constrictor response delays the correction of renal blood flow that occurs with fluctuations in systemic pressure, which allows pressure swings to be transmitted to the microvasculature, thus increasing the susceptibility to renal injury and hypertension. The role of ENaC in myogenic regulation is independent of tubular ENaC and thus represents a non-tubular role for ENaC in renal-cardiovascular homeostasis.

 

© 2015 ACT. All rights reserved.

 

Key words: Autoregulation; Epithelial sodium channel; Blood pressure; Mechanotransduction; Myogenic response

 

Drummond HA, Stec DE. ENaC Acts as a Mechanosensor in Renal Vascular Smooth Muscle Cells That Contributes to Renal Myogenic Blood Flow Regulation, Protection From Renal Injury and Hypertension. Journal of Nephrology Research 2015; 1(1): 1-9 Available from: URL: http://www.ghrnet.org/index.php/jnr/article/view/1189

 

INTRODUCTION

Mechanotransduction in vascular tissues is a topic of physiologic and pathophysiologic importance. Chronic and transient mechanical forces contribute to development of atherosclerosis, angiogenesis, endothelial function, ischemia-reperfusion injury, myogenic constriction and hypertension. However, the molecular mechanisms underlying transduction of mechanical forces, particularly the transduction of transient mechanical forces into rapid changes in cellular function, remain unclear. Our laboratory has been investigating the molecular mechanism(s) underlying initiation of the myogenic response in renal vasculature.

 

What is the myogenic response and why is it important?

The myogenic response. The myogenic response was initially described over 100 years ago[1]. The response is initiated by intraluminal pressure-induced vessel wall stretch, which stretches VSMCs circumferentially arranged around the vessel[2,3]. In turn, VSMC stretch initiates a depolarization event, which is thought to activate secondary signaling pathways, which include but are not limited to, voltage gated Ca2+ channels. Ca2+ channel activation stimulates Ca2+ influx and triggers vasoconstriction (Figure 1A)[2,3].  The molecular mechanism underlying the initial depolarizing event remains unresolved.

    Physiological significance of myogenic constriction: regulation of renal blood flow and protection from injury. The myogenic response is important because it participates in two processes. First, it is a mechanism of renal blood flow autoregulation, where blood flow is tightly controlled despite changes in systemic perfusion pressure between 50 and 150 mmHg[4,5]. Myogenic constriction is fast acting and adjusts vascular resistance to a change in perfusion pressure within 5-10 sec. The other mechanism of renal blood flow autoregulation, tubuloglomerular feedback (TGF), is slower and adjusts vascular resistance within 6-25 sec[6-9]. The fast nature of the myogenic response has led investigators to suggest another purpose of the myogenic response is the prevention of high systemic pressure transmission to the glomerular microvasculature, thus protecting microvasculature from pressure-related injury associated with hypertension, diabetes, and end stage renal disease[10,11]. While much is understood about signaling mechanisms underlying VSMC contraction, our understanding of the signaling mechanisms that transduce changes in intraluminal pressure into a cellular signaling event, i.e. the events that initiate myogenic constriction, is limited. We hypothesize that degenerin proteins may act as mechanosensors that transduce stretch into a cellular event.

 

Evolutionary role of degenerin proteins as mechanosensors

Degenerin proteins are a large family of proteins expressed in a diverse range of species, including the nematode, Caenorhabditis elegans (C. elegans), Drosophila and mammals. This family has strong evolutionary ties to mechanotransduction in neuronal and muscle tissues[12-21]. Members of this family share a common structure: intracellular N- and C- termini and a single large extracellular domain of approximately 400 residues separated by two membrane-spanning domains. Many of the degenerin proteins form homo- and heteromultimeric, non-voltage gated, Na+/cation channels[14,15,19].

    In mammals, two subfamilies of degenerin proteins have been identified: the Epithelial Na+ Channel (ENaC) and Acid Sensing Ion Channel (ASIC)  proteins. ENaC proteins are known for their role in Na+ and water transport in the kidney, lung, and colon epithelia. In these tissues, and ENaC proteins form a non-voltage gated, Na+ selective ion channel. The ENaC channel is inhibited by submicromolar to low micromolar concentrations of the diuretic amiloride and its analog benzamil. ENaC proteins are also expressed at several important sites of mechanotransduction including somatic touch receptors in skin, osteoclasts, keratinocytes, arterial baroreceptor neurons, endothelial cells and VSMCs[16,22-26]. Because of their close evolutionary relationship to the C. elegans degenerins, expression in mechanosensitive tissues, and ability to form ion channels, ENaC proteins have been considered as likely components of mechanosensors in vertebrate tissue.

    A model for a mammalian mechanosensor. Although a model of a mammalian mechanosensor has not been established, numerous genetic studies have led to the development of a mechanotransducer model in C. elegans neuronal and muscle tissue[18]. The model consists of three essential components: (1) an ion-conducting pore; (2) extracellular matrix and proteins that may link the pore to the matrix; and (3) cytoskeleton and proteins that may tether the pore to the cytoskeleton. Degenerin proteins form the ion channel pore. The extracellular matrix participates in force transduction and helps stabilize the ion-conducting pore at the cell surface. The cytoskeleton may also participate in transduction of the applied force and stabilize the ion-conducting pore at the cell surface. Based on the concept of evolutionary conservation of function, we hypothesize the mammalian mechanosensor is similar to the nematode model (Figure 1B). Activation of the mechanosensor leads to influx of Na+ and/or Ca2+ through a degenerin ion channel, which leads to an initial membrane depolarization and subsequent activation of VGCC.

 

 

Degenerin proteins are expressed in VSMCs and mediate renal myogenic constriction

To consider ENaC proteins as mechanosensors mediating pressure-induced constriction in blood vessels, ENaC proteins must be expressed in VSMCs and located at the site of mechanotransduction, near the cell surface and ENaC inhibition should abolish renal myogenic constriction. Therefore, initial studies focused on the expression/localization of ENaC proteins in VSMCs and the sensitivity of myogenic constriction to ENaC inhibition[23,27,28]. As shown in Figure 2A, VSMCs enzymatically dissociated from renal arterial segments express and ENaC, but not , at or near the cell surface membrane[27]. The localization pattern is significant because a strain sensing mechanosensor might be predicted to be located near the cell surface. The lack of ENaC in VSMCs is also an important finding. It has been suggested that the lack of ENaC would render a ENaC channel unable to conduct current in VSMCs, however, this is not entirely accurate as and ENaC can form an amiloride-sensitive, Na+ conducting channel in the absence of ENaC[29], albeit with reduced current. Additionally, the possibility of another subunit, such as an ASIC protein or unidentified ENaC, interacting with and ENaC to form a channel has not been ruled out.

    Our laboratory has taken multiple approaches to determine the importance of ENaC proteins in renal myogenic constriction, which includes (1) pharmacological inhibition; (2) transient gene silencing and (3) genetically modified mice[27,30,31]. One of our methods for assessment of myogenic constriction is shown in Figure 2B-E. Renal interlobar artery segments are dissected from surrounding tissue and mounted on two pipettes (Figure 2A). Artery segments are exposed to a step-wise (25 mmHg, 5 min) increase in perfusion pressure (Figure 2C, with Ca2+ containing and then Ca2+ free extracellular solution. Under Ca2+ containing conditions, artery segments constrict in response to the increase in pressure. However, under Ca2+ free conditions, vessels will passively dilate in response to the increase in pressure (Figure 2D). Myogenic tone at each pressure step is calculated as the difference in diameter between Ca2+ containing and Ca2+ free conditions divided by Ca2+ free diameter. A vessel segment with a myogenic response will exhibit an increase in tone with an increase in pressure. The pressure-myogenic tone relationship will be flat in a vessel with a weakened myogenic response (Figure 2E). If degenerin proteins are important in the transduction of myogenic constriction, then the relationship between pressure and myogenic tone should be altered following degenerin inhibition.

    To determine if members of the degenerin protein family contribute to the transduction of the myogenic response, we initially used broad-spectrum degenerin inhibitors amiloride and its analog benzamil[27]. ENaC inhibition with benzamil abolishes myogenic constriction in renal interlobar arteries in a concentration dependent manner (Figure 2F). Amiloride, data not shown, elicited a similar inhibition of myogenic constriction. An important factor in the interpretation of these experiments is the selectivity of the ENaC inhibitors. At submicromolar and low micromolar doses, benzamil is a fairly selective inhibitor of ENaC. Furthermore, recent studies by Guan et al. and Nagasawa et al. suggest myogenic constriction in rat afferent arterioles is also sensitive to ENaC inhibition[32,33]. However, another study by Wang et al found benzamil did not inhibit myogenic constriction in renal arterioles[34].

    While pharmacological inhibition is a tool for screening for degenerin involvement, the contribution of specific subunits cannot be determined. Thus, to determine the importance of ENaC and ENaC in renal myogenic constriction, we used a second approach, siRNA and dominant-negative constructs. siRNA and dominant-negative constructs specifically silence or ENaC expression (~50-75%) in VSMCs in isolated mouse renal interlobar artery segments (Figure 2G and H)[31]. ENaC silencing inhibited pressure-induced constrictor responses by 40-80%, without altering the ability of the vessel to constrict to phenylephrine, suggesting the loss of vasoconstriction is specific to pressure rather than a generalized loss in the ability of the vessel to constrict.

    In our third approach, we evaluated renal afferent arteriole myogenic constriction in a mouse model with reduced levels of ENaC. The model, which is described in the following section, is characterized by a global reduction in ENaC levels, including renal VSMCs. We examined myogenic constriction using the attached afferent arteriole-glomerulus preparation in which a single afferent arteriole attached to a glomerulus is dissected from the kidney and perfused at 60, then 120 mmHg[30]. The afferent arterioles from the ENaC +/+ mice develop significant myogenic tone in response to the step increase in pressure. However, myogenic tone is nearly abolished in renal afferent arterioles from ENaC m/m mice, suggesting ENaC is a critical to transduction of pressure-induced constriction (Figure 3A). Thus, three separate lines of evidence suggest certain ENaC proteins play a pivotal role in the myogenic response.

 

 

Do degenerin proteins mediate mechanically gated currents?

While the studies addressed in the previous section demonstrate the importance of degenerin proteins to the myogenic response, they do not distinguish between a role as a mechanosensor that initiates the response or an amplifying mechanism. Early investigations into the mechanosensitivity of ENaC in heterologous systems were equivocal[16,35-38]. However, subsequent studies using endogenously expressing tissue are supportive of ENaCs mechanosensitivity. The application of negative pressure to isolated channels in cortical collecting duct cells can gate native ENaC channels, and shear stress can gate ENaC in both isolated rabbit cortical collecting duct and heterologously expressing oocytes suggest ENaC channels can be activated by mechanical forces[39-47]. However, not all mechanical forces are created equal and mechanosensors might be expected to exhibit modal specificity. For example, hypo-osmotic swelling and shear stress are mechanical forces, but they are not necessarily equivalent. Is it appropriate to expect osmotic swelling to activate a shear stress sensor? Based on our understanding of modal specificity in somatic touch receptors, probably not. Therefore, we should expect a mechanosensor that detects strain to be activated by stretch.

Since the importance of strain/stretch in activating a mammalian degenerin has not been addressed, our laboratory developed a novel in-vitro electrophysiologic assay to assess mechanically gated currents in isolated VSMCs using stretch[48]. Briefly, enzymatically dissociated renal VSMCs are plated on an elasmoteric substrate coated with collagen. Cells are patched in a whole-cell configuration and the underlying membrane is stretched, which in turn, stretches the VSMCs along its long axis (~2 µm). The stretch initiates a small  but rapid, transient, Na+ dependent, inward current (Figure 3B). As expected, the magnitude of the current is dependent on the magnitude of the stretch. The current is nearly abolished in renal VSMCs obtained from ENaC m/m mice (Figure 3C). These later data are very important as they demonstrate that stretch gated currents in renal VSMCs are mediated by ENaC.

 

 

The ENaC m/m mouse: a model to determine the physiological importance of ENaC mediated myogenic constriction

Our early studies using pharmacological and gene silencing approaches indicated an important role for ENaC in myogenic constriction; however, understanding the consequences of long-term loss of myogenic constriction on cardiovascular health required a genetic model. For these studies, we used a model of reduced ENaC (ENaC m/m), rather than ENaC knockout mice as they die shortly after birth. The ENaC m/m model, developed by Bernard Rossier and Edith Hummler at the University of Lausanne, Switzerland[49,50], was generated using standard gene targeting approaches in the course of generating a model of Liddles syndrome (increased ENaC) by the insertion a premature stop codon in the C-terminus coding region. However, the neomycin selection marker disrupts the ENaC gene locus resulting in reduced ENaC expression. Thus, a mouse model that under-, rather than over-expresses, ENaC was generated. Mice homozygous for the mutation (m/m) express very low levels of ENaC transcripts and/or protein in the lung, kidney and VSMCs, including renal afferent arterioles[30,38,50-52]. Importantly, myogenic constriction in the renal afferent arteriole is abolished, as addressed in the previous section[30]. Since the afferent arteriole is the primary site of development of vascular resistance in the kidney, ENaC mediated myogenic constriction likely contributes to control of whole kidney vascular resistance and blood flow regulation.

Myogenic regulation of renal blood flow is attenuated in ENaC m/m mice

To address the physiologic and pathophysiologic importance of ENaC mediated renal myogenic constriction in the regulation of whole kidney blood flow (RBF), we used the ENaC m/m mouse model. We utilized the temporal separation between the onset of the myogenic mechanism (0-5 sec) and the TGF mechanism (6-25 sec) to determine the contribution of ENaC to myogenic regulation of RBF[30,52]. In these studies, mice were instrumented with a carotid arterial catheter for blood pressure measurement and a renal flow probe for measurement of whole kidney blood flow (Figure 4A). A step increase in blood pressure was achieved with an occlusion of the lower abdominal aorta, just below the renal artery (Figure 4A, B). RBF increases and RVR decreases immediately following the step increase in pressure (Figure 4C and D). Within 5-10 sec, RBF begins to return to control levels in +/+ animals due to myogenically mediated increase in RVR. In contrast, RBF remains elevated and RVR reduced in the m/m mice, suggesting a loss of myogenic regulation.

    We quantified the speed of the myogenic mechanism by the determining the rate of change in whole kidney RVR during the first 5 seconds following a step increase in renal perfusion pressure (Slope RVR0-5sec, Figure 4E). In both studies, we found a significant delay in the correction of RBF following a step increase in perfusion pressure in ENaC m/m mice[30,52]. To minimize any confounding influence of TGF, we examined renal hemodynamic responses to a step increase in pressure following acute volume expansion to reduce the contribution of TGF to vascular resistance[53-55]. We found myogenic speed was suppressed nearly 80% (Figure 4E), findings that parallel our in-vitro findings (loss of myogenic constriction in afferent arterioles) in ENaC m/m mice.

 

 

Signs of renal inflammation and mild injury in the ENaC m/m mouse

Inappropriate regulation of RBF is linked to renal injury in hypertension and diabetes[56,57]. Normally, swings in systemic pressure are prevented from reaching delicate renal microvasculature because of autoregulatory mechanisms; when systemic pressure rises, autoregulatory mechanisms are activated leading to vasoconstriction, thus preventing transmission of higher systemic pressures to delicate microvessels[56-59]. Since the myogenic response responds rapidly to changes in perfusion pressure, it is considered an important mechanism to prevent transmission of pressure swings to the microvasculature. We considered the possibility that ENaC m/m mice might have signs of renal injury and possibly, elevated blood pressure due to their reduced myogenic capacity. To address this possibility, we examined kidneys for indicators of renal injury and found signs of inflammation and mild renal injury characterized by increased levels of renal inflammatory cytokines (TNF, IL1, IL6), inflammatory cells (macrophages, lymphocytes), growth factors linked to pressure-dependent injury (TGF), and mild expansion of extracellular matrix[51]. We also found mean blood pressure is ~15 mm Hg higher than wildtype littermates (Figure 5)[51]. These findings demonstrate a link between altered ENaC mediated myogenic function, renal injury and hypertension.

 

 

Why isnt the ENaC m/m mouse hypotensive? 

Because the ENaC m/m mouse was generated using homologous recombination, reduced levels of ENaC would be expected in all tissues, including renal tubular cells. Loss of tubular ENaC related salt and water transport would be expected to lead to reduced or normal blood pressure with compensatory up-regulation of sodium retaining hormones. Thus, at first consideration, our finding that blood pressure is elevated in the ENaC m/m may seem counter-intuitive. However, when the elevated blood pressure data is taken in context with loss of myogenic autoregulation and presence of renal inflammation in the ENaC m/m, renal injury dependent increase in blood pressure seems plausible (Figure 6).

 

 

Future directions

There is much that needs to be done to elucidate the role of degenerins in vascular function. Pressure-dependent renal injury is a leading cause of end-stage renal disease with substantial financial costs (Medicare Care costs exceeded $26 billion in 2010)[60,61]. Understanding the degenerin mediated protection from injury will lead to development of approaches to prevent renal injury. Although the loss of renal pressure-dependent vascular function in ENaC m/m mice does not lead to severe renal injury and hypertension, it is not clear if a second hit, such as high Na+ diet, elevated angiotensin II, or added psychological stress would increase the severity of injury. Furthermore, information learned from the renal circulation may also apply to other myogenically active circulations, such as the cardiac and cerebral beds, which are often the targets of hypertension-induced injury.

    Another important future direction is the determination of the identity of other proteins that form the heteromultimeric mechanosensor in VSMCs. Based on the C. elegans model, the mechanosensor is a large heteromeric complex in which the pore is tethered to the cytoskeleton and extracellular matrix. The identity of the other pore forming subunit(s) and the cytoskeleton and extracellular matrix proteins responsible for tethering the pore have not been identified in mammals. Understanding their identity and regulation by hormonal, inflammatory, and autocrine factors may provide additional insight into the prevention and treatment of renal injury. It is very likely that VSMC ENaC protein expression and/or function may be altered in hypertension because many of the usual suspects implicated in hypertension (i.e. endothelin, aldosterone, angiotensin II, inflammatory cytokines, reactive oxygen species, and nitric oxide, dietary salt) regulate epithelial ENaC expression[28,62-72].

 

Summary

Our laboratory has considered degenerin proteins, specifically ENaC, as a component of a VSMC mechanosensor because of the strong evolutionary link to mechanotransduction in C. elegans. This hypothesis is supported by multiple lines of in-vitro and in-vivo evidence including (1) appropriate protein localization; (2) disruption of myogenic constriction in isolated vessels using pharmacological, transient gene silencing and genetically modified animals; (3) disruption of stretch gated whole cells currents in renal VSMCs and (4) disruption of myogenically mediated whole organ blood flow in vivo (Table 1). Furthermore, the importance of degenerin mediated vascular function on cardiovascular health is becoming clear; loss of vascular degenerin function may inhibit the protective renal myogenic mechanism, thereby increasing susceptibility to pressure related renal injury and hypertension.

 

 

Acknowledgements

This work was supported by NIH HL086996, P01HL051971, P20GM104357 as well as from the American Heart Association- AHA 2041002.

 

CONFLICT OF INTERESTS 

The authors declare no conflict of interest.

 

REFERENCES

1         Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28: 220-231, 1902.

2         Davis MJ and Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423, 1999.

3         Hill MA, Zou H, Potocnik SJ, Meininger GA, and Davis MJ. Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 91: 973-983, 2001.

4         Navar LG. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol 234: F357-370, 1978.

5         Navar LG, Marsh DJ, Blantz RC, Hall J, Ploth DW, and Nasjletti A. Intrinsic control of renal hemodynamics. Fed Proc 41: 3022-3030, 1982.

6         Cupples WA and Braam B. Assessment of renal autoregulation. Am J Physiol Renal Physiol 292: F1105-1123, 2007.

7         Cupples WA, Novak P, Novak V, and Salevsky FC. Spontaneous blood pressure fluctuations and renal blood flow dynamics. Am J Physiol 270: F82-89, 1996.

8         Just A and Arendshorst WJ. Dynamics and contribution of mechanisms mediating renal blood flow autoregulation. Am J Physiol Regul Integr Comp Physiol 285: R619-631, 2003.

9         Just A and Arendshorst WJ. A novel mechanism of renal blood flow autoregulation and the autoregulatory role of A1 adenosine receptors in mice. Am J Physiol Renal Physiol 293: F1489-1500, 2007.

10     Loutzenhiser R, Bidani A, and Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res 90: 1316-1324, 2002.

11     Marsh DJ, Sosnovtseva OV, Pavlov AN, Yip KP, and Holstein-Rathlou NH. Frequency encoding in renal blood flow regulation. Am J Physiol Regul Integr Comp Physiol 288: R1160-1167, 2005.

12     Arnadottir J and Chalfie M. Eukaryotic mechanosensitive channels. Annu Rev Biophys 39: 111-137, 2010.

13     Benos DJ and Stanton BA. Functional domains within the degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels. J Physiol 520 Pt 3: 631-644, 1999.

14     Goodman MB and Schwarz EM. Transducing touch in Caenorhabditis elegans. Annu Rev Physiol 65: 429-452, 2003.

15     Kellenberger S and Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 82: 735-767, 2002.

16     Kizer N, Guo XL, and Hruska K. Reconstitution of stretch-activated cation channels by expression of the alpha-subunit of the epithelial sodium channel cloned from osteoblasts. Proc Natl Acad Sci U S A 94: 1013-1018, 1997.

17     Mano I and Driscoll M. DEG/ENaC channels: a touchy superfamily that watches its salt. Bioessays 21: 568-578, 1999.

18     Syntichaki P and Tavernarakis N. Genetic models of mechanotransduction: the nematode Caenorhabditis elegans. Physiol Rev 84: 1097-1153, 2004.

19     Tavernarakis N and Driscoll M. Degenerins. At the core of the metazoan mechanotransducer? Ann N Y Acad Sci 940: 28-41, 2001.

20     Tavernarakis N and Driscoll M. Molecular modeling of mechanotransduction in the nematode Caenorhabditis elegans. Annu Rev Physiol 59: 659-689, 1997.

21     Trujillo E, Alvarez de la Rosa D, Mobasheri A, Gonzalez T, Canessa CM, and Martin-Vasallo P. Sodium transport systems in human chondrocytes. II. Expression of ENaC, Na+/K+/2Cl- cotransporter and Na+/H+ exchangers in healthy and arthritic chondrocytes. Histol Histopathol 14: 1023-1031, 1999.

22     Drummond HA, Abboud FM, and Welsh MJ. Localization of beta and gamma subunits of ENaC in sensory nerve endings in the rat foot pad. Brain Res 884: 1-12, 2000.

23     Drummond HA, Gebremedhin D, and Harder DR. Degenerin/epithelial Na+ channel proteins: components of a vascular mechanosensor. Hypertension 44: 643-648, 2004.

24     Drummond HA, Welsh MJ, and Abboud FM. ENaC subunits are molecular components of the arterial baroreceptor complex. Ann N Y Acad Sci 940: 42-47, 2001.

25     Mauro T, Guitard M, Behne M, Oda Y, Crumrine D, Komuves L, Rassner U, Elias PM, and Hummler E. The ENaC channel is required for normal epidermal differentiation. J Invest Dermatol 118: 589-594, 2002.

26     Wang S, Meng F, Mohan S, Champaneri B, and Gu Y. Functional ENaC channels expressed in endothelial cells: a new candidate for mediating shear force. Microcirculation 16: 276-287, 2009.

27     Jernigan NL and Drummond HA. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol 289: F891-901, 2005.

28     Jernigan NL, LaMarca B, Speed J, Galmiche L, Granger JP, and Drummond HA. Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am J Physiol Heart Circ Physiol 294: H409-420, 2008.

29     Bonny O, Chraibi A, Loffing J, Jaeger NF, Grunder S, Horisberger JD, and Rossier BC. Functional expression of a pseudohypoaldosteronism type I mutated epithelial Na+ channel lacking the pore-forming region of its alpha subunit. J Clin Invest 104: 967-974, 1999.

30     Ge Y, Gannon KP, Gousset M, Liu R, Murphey B, and Drummond HA. Impaired myogenic constriction of the renal afferent arteriole in a mouse model of reduced betaENaC expression. Am J Physiol Renal Physiol, 2012.

31     Jernigan NL and Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and gammaENaC. Am J Physiol Renal Physiol 291: F1184-1191, 2006.

32     Guan Z, Pollock JS, Cook AK, Hobbs JL, and Inscho EW. Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles. Hypertension 54: 1062-1069, 2009.

33     Nagasawa T and Imig JD. Afferent Arteriolar Responses to beta,gamma-methylene ATP and 20-HETE are not Blocked by ENaC Inhibition. Physiol Rep 1: e00082, 2013.

34     Wang X, Takeya K, Aaronson PI, Loutzenhiser K, and Loutzenhiser R. Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol 295: F272-282, 2008.

35     Awayda MS and Subramanyam M. Regulation of the epithelial Na+ channel by membrane tension. J Gen Physiol 112: 97-111, 1998.

36     Ismailov, II, Berdiev BK, Shlyonsky VG, and Benos DJ. Mechanosensitivity of an epithelial Na+ channel in planar lipid bilayers: release from Ca2+ block. Biophys J 72: 1182-1192, 1997.

37     Ji HL, Fuller CM, and Benos DJ. Osmotic pressure regulates alpha beta gamma-rENaC expressed in Xenopus oocytes. Am J Physiol 275: C1182-1190, 1998.

38     VanLandingham LG, Gannon KP, and Drummond HA. Pressure-induced constriction is inhibited in a mouse model of reduced betaENaC. Am J Physiol Regul Integr Comp Physiol 297: R723-728, 2009.

39     Abi-Antoun T, Shi S, Tolino LA, Kleyman TR, and Carattino MD. Second transmembrane domain modulates epithelial sodium channel gating in response to shear stress. Am J Physiol Renal Physiol 300: F1089-1095, 2011.

40     Carattino MD, Liu W, Hill WG, Satlin LM, and Kleyman TR. Lack of a role of membrane-protein interactions in flow-dependent activation of ENaC. Am J Physiol Renal Physiol 293: F316-324, 2007.

41     Carattino MD, Sheng S, and Kleyman TR. Epithelial Na+ channels are activated by laminar shear stress. J Biol Chem 279: 4120-4126, 2004.

42     Carattino MD, Sheng S, and Kleyman TR. Mutations in the pore region modify epithelial sodium channel gating by shear stress. J Biol Chem 280: 4393-4401, 2005.

43     Fronius M and Clauss WG. Mechano-sensitivity of ENaC: may the (shear) force be with you. Pflugers Arch 455: 775-785, 2008.

44     Ma HP, Li L, Zhou ZH, Eaton DC, and Warnock DG. ATP masks stretch activation of epithelial sodium channels in A6 distal nephron cells. Am J Physiol Renal Physiol 282: F501-505, 2002.

45     Morimoto T, Liu W, Woda C, Carattino MD, Wei Y, Hughey RP, Apodaca G, Satlin LM, and Kleyman TR. Mechanism underlying flow stimulation of sodium absorption in the mammalian collecting duct. Am J Physiol Renal Physiol 291: F663-669, 2006.

46     Palmer LG and Frindt G. Gating of Na channels in the rat cortical collecting tubule: effects of voltage and membrane stretch. J Gen Physiol 107: 35-45, 1996.

47     Satlin LM, Sheng S, Woda CB, and Kleyman TR. Epithelial Na(+) channels are regulated by flow. Am J Physiol Renal Physiol 280: F1010-1018, 2001.

48     Chung WS, Weissman JL, Farley J, and Drummond HA. betaENaC is required for whole cell mechanically gated currents in renal vascular smooth muscle cells. Am J Physiol Renal Physiol 304: F1428-1437, 2013.

49     McDonald FJ, Yang B, Hrstka RF, Drummond HA, Tarr DE, McCray PB, Jr., Stokes JB, Welsh MJ, and Williamson RA. Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A 96: 1727-1731, 1999.

50     Pradervand S, Barker PM, Wang Q, Ernst SA, Beermann F, Grubb BR, Burnier M, Schmidt A, Bindels RJ, Gatzy JT, Rossier BC, and Hummler E. Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci U S A 96: 1732-1737, 1999.

51     Drummond HA, Grifoni SC, Abu-Zaid A, Gousset M, Chiposi R, Barnard JM, Murphey B, and Stec DE. Renal inflammation and elevated blood pressure in a mouse model of reduced {beta}-ENaC. Am J Physiol Renal Physiol 301: F443-449, 2011.

52     Grifoni SC, Chiposi R, McKey SE, Ryan MJ, and Drummond HA. Altered whole kidney blood flow autoregulation in a mouse model of reduced beta-ENaC. Am J Physiol Renal Physiol 298: F285-292, 2010.

53     Kawata T, Ando A, Hatano M, Onuki T, and Sugino N. Tubuloglomerular feedback resetting in different models of acute volume expansion. Kidney Int Suppl 32: S148-152, 1991.

54     Persson AE, Schnermann J, and Wright FS. Modification of feedback influence on glomerular filtration rate by acute isotonic extracellular volume expansion. Pflugers Arch 381: 99-105, 1979.

55     Schnermann J and Briggs JP. Restoration of tubuloglomerular feedback in volume-expanded rats by angiotensin II. Am J Physiol 259: F565-572, 1990.

56     Bidani AK, Hacioglu R, Abu-Amarah I, Williamson GA, Loutzenhiser R, and Griffin KA. "Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol 285: F113-120, 2003.

57     Bidani AK, Picken M, Hacioglu R, Williamson G, and Griffin KA. Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol 292: F647-654, 2007.

58     Griffin KA, Hacioglu R, Abu-Amarah I, Loutzenhiser R, Williamson GA, and Bidani AK. Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation. Am J Physiol Renal Physiol 286: F1136-1143, 2004.

59     Loutzenhiser R, Griffin KA, and Bidani AK. Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory? Curr Opin Nephrol Hypertens 15: 41-49, 2006.

60     USRDS USRDS. Economic costs of ESRD, 2008, 2008.

61     USRDS USRDS. Incidence and prevalence of ESRD, 2010. 2010.

62     Amasheh S, Barmeyer C, Koch CS, Tavalali S, Mankertz J, Epple HJ, Gehring MM, Florian P, Kroesen AJ, Zeitz M, Fromm M, and Schulzke JD. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology 126: 1711-1720, 2004.

63     Barmeyer C, Amasheh S, Tavalali S, Mankertz J, Zeitz M, Fromm M, and Schulzke JD. IL-1beta and TNFalpha regulate sodium absorption in rat distal colon. Biochem Biophys Res Commun 317: 500-507, 2004.

64     Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, and Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 41: 1143-1150, 2003.

65     Chung WS, Farley JM, and Drummond HA. ASIC-like currents in freshly isolated cerebral artery smooth muscle cells are inhibited by endogenous oxidase activity. Cell Physiol Biochem 27: 129-138, 2011.

66     Drummond HA, Furtado MM, Myers S, Grifoni S, Parker KA, Hoover A, and Stec DE. ENaC proteins are required for NGF-induced neurite growth. Am J Physiol Cell Physiol 290: C404-410, 2006.

67     Gilmore ES, Stutts MJ, and Milgram SL. SRC family kinases mediate epithelial Na+ channel inhibition by endothelin. J Biol Chem 276: 42610-42617, 2001.

68     Helms MN, Jain L, Self JL, and Eaton DC. Redox regulation of epithelial sodium channels examined in alveolar type 1 and 2 cells patch-clamped in lung slice tissue. J Biol Chem 283: 22875-22883, 2008.

69     Jernigan NL, Speed J, LaMarca B, Granger JP, and Drummond HA. Angiotensin II regulation of renal vascular ENaC proteins. Am J Hypertens 22: 593-597, 2009.

70     Mamet J, Baron A, Lazdunski M, and Voilley N. Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci 22: 10662-10670, 2002.

71     Mamet J, Lazdunski M, and Voilley N. How nerve growth factor drives physiological and inflammatory expressions of acid-sensing ion channel 3 in sensory neurons. J Biol Chem 278: 48907-48913, 2003.

72     Pavlov TS, Chahdi A, Ilatovskaya DV, Levchenko V, Vandewalle A, Pochynyuk O, Sorokin A, and Staruschenko A. Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2. J Am Soc Nephrol 21: 833-843, 2010.

 

Peer reviewer: Bianjiang Liu, Department of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing 210029, China.

 

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.